JONG SOO WOO,JAE HYUN PARK,YOUNGSU YOON,LEEDONG ROH,HO TAEK IM,YONG IL KIM
申请号：
ARP160100825
公开号：
AR105758A1
申请日:
2016.03.29
申请国别(地区):
AR
年份:
2017
代理人:
摘要：
Claim 1: a complex Pharmaceutical Formulation for preventing or treating cardiovascular diseases, which comprises: a First mixture formulation comprising Amlodipine or one of its Salts are acceptable from the standpoint of Pharmaceuticals, chlorthalidone or one of its Salts accepts And from the point of view of pharmaceuticalAdditive and a Pharmaceutical acceptable from the point of view； and a Second mixture which includes Losartan or one of its Salts are acceptable from the point of view of pharmaceutical Additive, and a Pharmaceutical acceptable from the point of view, where the first and second mixture mixture are present In a physically separated from one another.Claim 11: a method for preparing a Pharmaceutical Formulation for preventing or treating Complex cardiovascular diseases, wherein the method comprises the steps of: a) mixing Amlodipine or one of its Salts are acceptable from the standpoint of its Pharmaceutical, chlorthalidone or Are acceptable from the standpoint of pharmaceuticalAdditive and a Pharmaceutical acceptable from the point of view； and b) mixing Losartan or one of its Salts are acceptable from the point of view of pharmaceutical Additive, and a Pharmaceutical acceptable from the point of view.Reivindicación 1: Una formulación farmacéutica compleja para prevenir o tratar las enfermedades cardiovasculares, donde la formulación comprende: una primera mezcla que incluye amlodipina o una de sus sales aceptables desde el punto de vista farmacéutico, clortalidona o una de sus sales aceptables desde el punto de vista farmacéutico, y un aditivo aceptable desde el punto de vista farmacéutico； y una segunda mezcla que incluye losartan o una de sus sales aceptables desde el punto de vista farmacéutico, y un aditivo aceptable desde el punto de vista farmacéutico, en donde la primera mezcla y la segunda mezcla están presentes en una forma separada físicamente una de la otra. Reivindicación 11: Un método para preparar una formulación farmacéutica comple
